Therapix Biosciences Ltd. Share Price Nasdaq
Equities
US88339A2033
Pharmaceuticals
Sales 2022 | 1.35 105.34 | Sales 2023 | 2.88 225.15 | Capitalization | 2.56M 200M |
---|---|---|---|---|---|
Net income 2022 | -2M -156M | Net income 2023 | -5M -391M | EV / Sales 2022 | 1,145,812 x |
Net cash position 2022 | 3.55M 277M | Net cash position 2023 | 5M 391M | EV / Sales 2023 | -848,893 x |
P/E ratio 2022 |
-1.33
x | P/E ratio 2023 |
-0.34
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+15.71% | 15.02B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-10.97% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.28% | 5.59B |